Needham Reiterates Buy on Paragon 28, Maintains $24 Price Target
Needham analyst Mike Matson reiterates Paragon 28 (NYSE:FNA) with a Buy and maintains $24 price target.
Paragon 28 Q4 Sales $51.51M Beat $50.44M Estimate
Paragon 28 (NYSE:FNA) reported quarterly sales of $51.51 million which beat the analyst consensus estimate of $50.44 million by 2.12 percent. This is a 20.42 percent increase over sales of $42.77 million the same period
Earnings Scheduled For March 2, 2023
Companies Reporting Before The Bell
• argenx (NASDAQ:ARGX) is expected to report quarterly loss at $3.03 per share on revenue of $176.89 million.
Reported Late Wednesday, Paragon 28 Announces Pricing Of $63.8M Public Offering Of $6.5M Shares Of Common Stock At A Price Of $17/Share
Paragon 28, Inc. (NYSE:FNA) ("Paragon"), a leading medical device company exclusively focused on the foot and ankle orthopedic market, announced today the pricing of the previously announced underwritten public
B. Riley Securities Initiates Coverage On Paragon 28 with Buy Rating, Announces Price Target of $32
B. Riley Securities analyst Neil Chatterji initiates coverage on Paragon 28 (NYSE:FNA) with a Buy rating and announces Price Target of $32.
Needham Maintains Buy on Paragon 28, Raises Price Target to $24
Needham analyst Mike Matson maintains Paragon 28 (NYSE:FNA) with a Buy and raises the price target from $20 to $24.
Paragon 28 Q1 EPS $(0.12) Misses $(0.06) Estimate, Sales $41.40M Beat $37.47M Estimate
Paragon 28 (NYSE:FNA) reported quarterly losses of $(0.12) per share which missed the analyst consensus estimate of $(0.06) by 100 percent. The company reported quarterly sales of $41.40 million which beat the analyst
Earnings Scheduled For May 9, 2022
Companies Reporting Before The Bell
• Atlantica Sustainable (NASDAQ:AY) is likely to report quarterly loss at $0.08 per share on revenue of $277.90 million.
B of A Securities Maintains Buy on Paragon 28, Lowers Price Target to $25
B of A Securities analyst Craig Bijou maintains Paragon 28 (NYSE:FNA) with a Buy and lowers the price target from $30 to $25.
Earnings Scheduled For March 8, 2022
Companies Reporting Before The Bell
• Babcock & Wilcox (NYSE:BW) is likely to report quarterly earnings at $0.10 per share on revenue of $196.62 million.